Assessing Pneumonia Risk in Antipsychotic Medication Use

This chapter examines the increased pneumonia risk linked to certain antipsychotic medications with anticholinergic properties, focusing on high-dose quetiapine usage. It advocates for routine pneumonia risk assessments in elderly patients and explores the safety of antipsychotic polypharmacy compared to high-dose monotherapy.